SLC1A5 and colorectal cancer: It was reported that the inhibition of ASCT2 repressed reduced cancer cell growth and proliferation in LS174T cell line.3 Thus, it was assumed that ASCT2 might be a candidate target for the intervention of colon cancer, whereas the underlying role of ASCT2 in the pathogenesis of colorectal cancer remains not fully understood.